Literature DB >> 25172014

Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.

Benoit Chassaing1, Ruth E Ley2, Andrew T Gewirtz3.   

Abstract

BACKGROUND & AIMS: Mice lacking the receptor Toll-like receptor 5 (TLR5-null mice), which recognizes flagellin, have an altered intestinal microbiota composition compared with wild-type mice; they develop low-grade inflammation and metabolic syndrome and are prone to colitis. The relative roles of intestinal epithelial cell (IEC) vs dendritic cell (DC) TLR5 in mediating these phenotypes are not clear; modification of intestinal microbiota composition has been reported to reflect animal husbandry practices rather than loss of TLR5. We generated mice with specific disruption of Tlr5 in IECs or DCs by using a breeding scheme that allows comparison with cohoused siblings as controls.
METHODS: We generated C57BL/6 mice with LoxP sites flanking Tlr5. These mice were crossed with mice expressing Cre recombinase, regulated by the villin or CD11c promoters, to generate mice that lacked expression of TLR5 by IECs (TLR5(ΔIEC)) or DCs (TLR5(ΔDC)), respectively. Tlr5(fl/fl) siblings were used as controls. On weaning, mice were housed by sex and genotype or by sex only (genotypes cohoused). Mice were examined for basal phenotypes, including microbiota composition; we also analyzed responses to pathobiont challenge, administration of dextran sodium sulfate, and high-fat diets.
RESULTS: Similar to previous findings from TLR5-null mice, TLR5(ΔIEC) mice had low-grade inflammation (mild splenomegaly, shortened colons, and increased fecal levels of lipocalin 2), metabolic syndrome, and an inability to clear pathobionts and were prone to developing colitis compared with their sibling controls under both housing conditions. Development of this inflammation in the TLR5(ΔIEC) mice was eliminated by administration of antibiotics and associated with alterations in localization of microbiota and levels of fecal lipopolysaccharide and flagellin. The composition of the microbiota clustered more closely according to genotype than housing. Loss of TLR5 from DCs did not associate with development of inflammation-associated phenotypes or alterations in the composition of the microbiota but resulted in complete loss of flagellin-induced production of interleukin-22.
CONCLUSIONS: In mice, flagellin activation of TLR5 on DCs leads to production of interleukin-22. Expression of TLR5 on IECs regulates the composition and localization of the intestinal microbiota, preventing diseases associated with intestinal inflammation.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IBD; Intestine; LPS; Mouse Model

Mesh:

Substances:

Year:  2014        PMID: 25172014      PMCID: PMC4253564          DOI: 10.1053/j.gastro.2014.08.033

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.

Authors:  Laurye Van Maele; Christophe Carnoy; Delphine Cayet; Pascal Songhet; Laure Dumoutier; Isabel Ferrero; Laure Janot; François Erard; Julie Bertout; Hélène Leger; Florent Sebbane; Arndt Benecke; Jean-Christophe Renauld; Wolf-Dietrich Hardt; Bernhard Ryffel; Jean-Claude Sirard
Journal:  J Immunol       Date:  2010-06-21       Impact factor: 5.422

2.  Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.

Authors:  Chin Wen Png; Sara K Lindén; Kristen S Gilshenan; Erwin G Zoetendal; Chris S McSweeney; Lindsay I Sly; Michael A McGuckin; Timothy H J Florin
Journal:  Am J Gastroenterol       Date:  2010-07-20       Impact factor: 10.864

3.  Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease.

Authors:  Andrew T Gewirtz; Matam Vijay-Kumar; Steven R Brant; Richard H Duerr; Dan L Nicolae; Judy H Cho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-26       Impact factor: 4.052

4.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.

Authors:  Malin E V Johansson; Mia Phillipson; Joel Petersson; Anna Velcich; Lena Holm; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

5.  Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.

Authors:  Namju Kim; Jun Kunisawa; Mi-Na Kweon; Geun Eog Ji; Hiroshi Kiyono
Journal:  Clin Immunol       Date:  2007-01-10       Impact factor: 3.969

6.  Cdc42 and Rac1 regulate late events in Salmonella typhimurium-induced interleukin-8 secretion from polarized epithelial cells.

Authors:  Michael E Hobert; Kara A Sands; Randal J Mrsny; James L Madara
Journal:  J Biol Chem       Date:  2002-10-14       Impact factor: 5.157

7.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

8.  Deletion of TLR5 results in spontaneous colitis in mice.

Authors:  Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.

Authors:  Benoit Chassaing; Omry Koren; Frederic A Carvalho; Ruth E Ley; Andrew T Gewirtz
Journal:  Gut       Date:  2013-07-29       Impact factor: 23.059

10.  Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice.

Authors:  Carles Ubeda; Lauren Lipuma; Asia Gobourne; Agnes Viale; Ingrid Leiner; Michele Equinda; Raya Khanin; Eric G Pamer
Journal:  J Exp Med       Date:  2012-07-23       Impact factor: 14.307

View more
  107 in total

1.  Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Authors:  Benyue Zhang; Benoit Chassaing; Zhenda Shi; Robin Uchiyama; Zhan Zhang; Timothy L Denning; Sue E Crawford; Andrea J Pruijssers; Jason A Iskarpatyoti; Mary K Estes; Terence S Dermody; Wenjun Ouyang; Ifor R Williams; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Science       Date:  2014-11-14       Impact factor: 47.728

Review 2.  Microbiota and host immune responses: a love-hate relationship.

Authors:  Sarah Tomkovich; Christian Jobin
Journal:  Immunology       Date:  2015-11-02       Impact factor: 7.397

3.  The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis.

Authors:  Agnieszka D Truax; Liang Chen; Jason W Tam; Ning Cheng; Hao Guo; A Alicia Koblansky; Wei-Chun Chou; Justin E Wilson; W June Brickey; Alex Petrucelli; Rongrong Liu; Daniel E Cooper; Mark J Koenigsknecht; Vincent B Young; Mihai G Netea; Rinke Stienstra; R Balfour Sartor; Stephanie A Montgomery; Rosalind A Coleman; Jenny P-Y Ting
Journal:  Cell Host Microbe       Date:  2018-09-12       Impact factor: 21.023

Review 4.  IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

5.  Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Authors:  Rémi Porte; Laurye Van Maele; Natalia Muñoz-Wolf; Benoit Foligné; Laure Dumoutier; Julien Tabareau; Delphine Cayet; Pierre Gosset; Nicolas Jonckheere; Isabelle Van Seuningen; José A Chabalgoity; Michel Simonet; Mohamed Lamkanfi; Jean-Christophe Renauld; Jean-Claude Sirard; Christophe Carnoy
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

6.  Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

Authors:  Siegfried Ussar; Nicholas W Griffin; Olivier Bezy; Shiho Fujisaka; Sara Vienberg; Samir Softic; Luxue Deng; Lynn Bry; Jeffrey I Gordon; C Ronald Kahn
Journal:  Cell Metab       Date:  2015-08-20       Impact factor: 27.287

Review 7.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

8.  Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health.

Authors:  Jun Zou; Benoit Chassaing; Vishal Singh; Michael Pellizzon; Matthew Ricci; Michael D Fythe; Matam Vijay Kumar; Andrew T Gewirtz
Journal:  Cell Host Microbe       Date:  2017-12-21       Impact factor: 21.023

9.  The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.

Authors:  Miles Fuller; Medha Priyadarshini; Sean M Gibbons; Anthony R Angueira; Michael Brodsky; M Geoffrey Hayes; Petia Kovatcheva-Datchary; Fredrik Bäckhed; Jack A Gilbert; William L Lowe; Brian T Layden
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-22       Impact factor: 4.310

Review 10.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.